Dosage adjustments or discontinuation may be necessary based on individual tolerance and provider assessment
Efficacy and tolerability of the dipeptidylpeptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes
Additionally, they can reduce the expression and activity of key iron uptake proteins such as transferrin receptor, divalent metal transporter 1 (DMT1), and zinc-iron transporters, while also modulating critical regulatory factors including iron-regulated proteins and hypoxia-inducible factor 1 (27)
these mechanisms have not yet been confirmed in clinical studies
The company is not BBB accredited, has a D- grade, and has a 1-star rating out of a potential five
Once the patent ends in India, local drugmakers can legally produce generic versions